Results 81 to 90 of about 16,131 (131)

Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool. [PDF]

J Nucl Med
Jeanjean P, Swaidan A, Tse C, Kwock S, Fajnorova I, Dove R, Azrour IC, Taylor S, Comin-Anduix B, Nathanson DA, Carlucci G, Calais J, Czernin J, Besserer-Offroy É, Mona CE.   +14 more
europepmc   +1 more source

Exploring the protease inhibitory potential of 2-bromo-2-nitro-1,3- propanediol (Bronopol): Initial findings. [PDF]

Biochem Biophys Rep
Jiang C, Krzyzanowski G, Fernando MR.
europepmc   +1 more source

Automated pharmacophore hypothesis generator for SILCS-Pharm: ph4gen. [PDF]

J Comput Aided Mol Des
Nordquist EB, MacKerell AD.
europepmc   +1 more source

Targeting Cathepsin C in Cancer Metastasis: Protease Network Activation, Inflammatory Crosstalk, and Therapeutic Opportunities. [PDF]

Int J Mol Sci
Liu Y, Hao L, Zheng L.
europepmc   +1 more source

Cathepsin Family Proteases in Prodrug Design: Recent Advances. [PDF]

ChemMedChem
Liu H, Zheng M, Ng CS, Loh TP.
europepmc   +1 more source

Expression of angiotensin-converting enzyme 2, transmembrane serine protease 2, and sirtuin 1 proteins in lungs of different age groups. [PDF]

J Bras Pneumol
Lamounier ACA, Froio FCL, Ribeiro Júnior G, Costa NSX, Brito JM, Silva-Filho LVRFD, Mauad T.   +6 more
europepmc   +1 more source

Mechanism of action and impact on thrombin generation of denecimig (Mim8), emicizumab, and zemocimig (NXT007): comparative analysis using sequence-identical analogs. [PDF]

Res Pract Thromb Haemost
Lund J, Egebjerg T, Bjelke JR, Ezban M.
europepmc   +1 more source

Safety of [⁶⁸Ga]Ga-FAPI-46 PET/CT including hemodynamic measurements and patient-reported outcomes in cancer patients. [PDF]

Clin Physiol Funct Imaging
Bentestuen M, Sylvest C, Jensen SB, Soro LR, Knudsen A, Ladekarl M, Thorlacius-Ussing O, Fendler WP, Zacho HD.   +8 more
europepmc   +1 more source